MedPath

Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Public, Subsidiary
Established
1992-01-01
Employees
741
Market Cap
-
Website
http://www.onyx-pharm.com

Clinical Trials

3

Active:3
Completed:0

Trial Phases

1 Phases

Phase 1:3

Drug Approvals

2

NMPA:1
FDA:1

Drug Approvals

Carfilzomib for Injection

Product Name
凯洛斯
Approval Number
国药准字HJ20210054
Approval Date
Jul 6, 2021
NMPA

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.